Adaptive Biotechnologies (ADPT) Non-cash Items (2018 - 2026)

Adaptive Biotechnologies has disclosed Non-cash Items across 9 years of filings, most recently posting $35.9 million for Q1 2026.

• Non-cash Items for Q1 2026 came in at $35.9 million, up 567.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $35.9 million (up 567.99% YoY), and the FY2025 annual result was $56982.0, down 97.36% from the prior year.
• Non-cash Items came in at $35.9 million for Q1 2026 at Adaptive Biotechnologies, up from $56982.0 in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $51.6 million in Q1 2022 to a low of $56982.0 in Q4 2025.
• The 5-year median for Non-cash Items is $4.2 million (2022), against an average of $10.6 million.
• Across the five-year window, Non-cash Items slumped 99.21% in 2024 and soared 24370.0% in 2025, its largest moves.
• Adaptive Biotechnologies' Non-cash Items stood at $6.7 million in 2022, then slumped by 92.39% to $506000.0 in 2023, then jumped by 326.28% to $2.2 million in 2024, then plunged by 97.36% to $56982.0 in 2025, then jumped by 62863.74% to $35.9 million in 2026.
• The last three Non-cash Items figures came in at $35.9 million (Q1 2026), $56982.0 (Q4 2025), and $15.4 million (Q3 2025), per Business Quant data.